SomaLogic to Announce Second Quarter 2023 Financial Results on August 14, 2023
24 Julho 2023 - 5:30PM
SomaLogic, Inc., a leader in proteomics technology, today announced
that it will report financial results for the second quarter 2023
after market close on August 14th, 2023. Management will host a
corresponding conference call beginning at 4:30 p.m. Eastern Time.
Those interested in listening to the conference
call should register online here. Participants are encouraged to
register more than 15 minutes before the start of the call. A live
and archived version of the webcast will be available at
https://investors.somalogic.com/.
About SomaLogicSomaLogic is
catalyzing drug research and development and biomarker
identification as a global leader in proteomics technology. With a
single 55 microliter plasma or serum sample, SomaLogic can run
7,000 protein measurements, covering more than a third of the
approximately 20,000 proteins in the human body and twice as many
as other proteomic platforms. For more than 20 years we’ve
supported pharmaceutical companies, and academic and contract
research organizations who rely on our protein detection and
analysis technologies to fuel drug, disease, and treatment
discoveries in such areas as oncology, diabetes, and
cardiovascular, liver and metabolic diseases. Find out more at
www.somalogic.com and follow @somalogic on LinkedIn.
Investor ContactMarissa
BychGilmartin Group LLCinvestors@somalogic.com
SomaLogic ContactEmilia
Costales720-798-5054ecostales@somalogic.com
SomaLogic (NASDAQ:SLGC)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
SomaLogic (NASDAQ:SLGC)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024